• The new FDA voucher program aims to speed approval of drugs aligned with national health priorities.
• NRX-100, a preservative-free ketamine, is also under an Abbreviated New Drug Application (“ANDA”) with a priority review request.
• NRx has submitted full CMC data and draft labeling for NRX-100, meeting key Commissioner’s National Priority Voucher pre-qualification criteria.
• The company’s U.S.-based manufacturing aims to reduce foreign supply chain dependence and address diversion concerns.
• A patent on the preservative-free process and a citizen petition to withdraw preserved ketamine could bolster NRx’s market position.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. The company has filed an application under the newly created FDA Commissioner’s National Priority Voucher (“CNPV”) program, which promises significantly shortened review timelines for drugs that meet urgent U.S. health priorities (https://ibn.fm/VeYud).

The new CNPV program, announced by FDA Commissioner Marty Makary on June 17, is intended to bring promising treatments to market more quickly. Makary had previously identified psychedelic drugs for treatment of suicidal depression and PTSD as a national priority. For eligible drugs, the program compresses the final review timeline from roughly 10–12 months down to 1–2 months. This streamlined pathway will be available to a limited number of companies aligned with public health priorities such as addressing the health crisis in the U.S., increasing domestic drug manufacturing, and the development of more innovative treatments.

NRX-100 appears to fit that profile. Developed as a preservative-free formulation of ketamine, the drug targets severe psychiatric conditions that have received renewed national attention. Suicide and PTSD have been highlighted by federal officials, including the U.S. president and Cabinet members, as areas requiring urgent intervention.

NRx emphasized that it has already submitted the Chemistry, Manufacturing, and Controls (“CMC”) portion of the application and received an FDA information request, which it has addressed. The company also submitted proposed labeling and reports stability and sterility data that suggest a three-year shelf life at room temperature, an important logistical benefit for hospital and clinical settings.

Jonathan C. Javitt, MD, MPH, Chairman and CEO of NRx, said the CNPV aligns with the company’s strategy. “As previously determined by FDA, our products are innovative treatments that address the current health crisis of suicidal depression and PTSD, and address an unmet medical need,” Javitt explained. “The FDA’s announcement has now validated our company’s focus on manufacturing and CMC by identifying CMC as a pre-requisite to the CNPV program. The timelines announced for the CNPV program are consistent with NRx’s previous guidance of FDA decisions (PDUFA date) by year-end 2025.”

In parallel, the company has filed an Abbreviated New Drug Application (“ANDA”) for NRX-100 with a request for priority review. The two pathways, CNPV and ANDA, are expected to complement one another, according to the company. Should the CNPV be granted, the drug could enter a Commissioner-led review program with integrated oversight from key FDA offices.

The formulation also has manufacturing and market advantages. NRX-100 is produced domestically in West Columbia, South Carolina, addressing concerns over reliance on international ketamine supply chains. The company has added anti-diversion measures to limit misuse, an important step in addressing the growing scrutiny around ketamine’s off-label use.

To further solidify its market position, NRx is pursuing a citizen petition to withdraw preservative-containing versions of ketamine, citing toxicity from benzethonium chloride. If successful, this could clear regulatory space for NRX-100 while reinforcing its safety claims. The company has also filed a patent on its preservative-free manufacturing process.

Ketamine is already approved for anesthesia and has seen expanded use in off-label psychiatric treatment. The current generic ketamine market, valued at around $750 million, is projected to grow to $3–5 billion by 2033. A preservative-free product with clear regulatory backing could appeal to both hospital buyers and psychiatric treatment centers seeking safer and more standardized formulations.

The FDA previously granted Fast Track designation to NRX-101, a combination therapy of NRX-100 and another compound, further indicating regulatory interest in the company’s approach to treating high-risk psychiatric conditions.

For more information, visit the company’s website at www.NRxPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

AI World Society Circle (“AIWS”) is proud to announce the San Francisco Chapter of its flagship After Hours AI World Society Circle event. This exclusive evening experience will offer a unique opportunity for attendees to connect with fellow AI enthusiasts, industry leaders, and innovators in a relaxed and positive atmosphere. It will offer unrivaled networking opportunities, engaging discussions, expert insights, as well as AI start-up pitches, allowing attendees to stay ahead of the curve on all matters AI.

AIWS is a global initiative dedicated to promoting ethical AI governance and responsible AI development. It is an institution that believes in the power of community-driven innovation, with regional chapters designed to bring together diverse perspectives and expertise to explore the challenges and opportunities posed by AI. Ever since its inception, AIWS has launched and established a presence in major global tech hubs, including Los Angeles, New York, Silicon Valley, Atlanta, Toronto, London, and Amsterdam.

The San Francisco Chapter will draw on the lessons learned from previous events, all of which have been lauded for providing excellent networking opportunities. They have also received high praise for the value they offer attendees from a knowledge perspective, with many noting how integral the events have been to their staying ahead in an industry that is quickly evolving.

With thought-provoking discussions and unrivaled networking opportunities, attendees of the After Hours AI World Society Circle have a chance to be part of the global AI discourse and shape the future of AI governance, ensuring that emerging technologies align with human values and respect for human rights.

To learn more, please visit https://ibn.fm/u558O

• Lantern Pharma uses a proprietary AI platform, RADR^®, to guide its oncology drug development, enabling rapid drug candidate identification and targeted trial design based on genomic and biomarker data.
• A Phase 2 trial patient achieved a complete response in their primary cancer lesions after multiple prior therapies failed and has remained responsive to LP-300 for two years signaling durable clinical benefit in this challenging population.
• The target population, never-smokers with non-small cell lung cancer, represents a growing global unmet need estimated at over $4 billion annually.

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with advanced non-small cell lung cancer (“NSCLC”) achieved a complete response using LP-300, a compound optimized through Lantern’s AI-powered platform, RADR(R) (https://ibn.fm/II6O6).

This outcome is particularly notable because the patient had previously undergone three unsuccessful lines of treatment, including immunotherapy and targeted kinase inhibitors. The patient’s sustained remission, now over two years, highlights the potential of AI-powered drug development to identify novel therapeutic opportunities for difficult-to-treat cancers.

RADR(R), short for Response Algorithm for Drug Positioning & Rescue, is Lantern’s proprietary platform for integrating large-scale genomic, biomarker, and preclinical data. The system is designed to uncover drug-cancer matches and synergistic combinations faster and more cost-effectively than traditional approaches. It was instrumental in advancing LP-300 by confirming its potential mechanism of action and compatibility with existing chemotherapy regimens.

In the HARMONIC(TM) trial, LP-300 is being tested in combination with pemetrexed and carboplatin, targeting never-smoker NSCLC patients who have progressed after prior kinase inhibitor therapy. The trial is randomized, open-label, and enrolling patients in the U.S., Japan, and Taiwan. With approximately 90 participants planned, the study compares LP-300 plus chemotherapy against chemotherapy alone.

The early signals are encouraging. Lantern’s lead-in cohort showed an 86% clinical benefit rate and a 43% objective response rate. In one case, a 70-year-old never-smoker with advanced disease showed a 57% tumor volume reduction in 2024. By early 2025, imaging confirmed a complete response in both lung and adrenal lesions. No dose-limiting toxicities or significant adverse reactions were reported over 21 cycles of treatment.

“This outcome provides important confirmation of our data and AI-driven approach to drug development and gives us growing confidence as we advance toward potential future registration-enabling studies for this underserved patient population that has no approved treatment options after failing targeted kinase therapies,” said Lantern CEO Panna Sharma, commenting on the results. “This remarkable case exemplifies several of the things we have hoped to observe with LP-300 in the HARMONIC trial. To see a heavily pre-treated patient not only achieve a complete response in their target cancer lesions but maintain that response with excellent quality of life is truly extraordinary,” Sharma added.

The never-smoker NSCLC population is clinically distinct. It has grown significantly over the past 30 years, from 15% to over 25% of lung cancer cases globally. In East Asia, never-smokers account for nearly 35% of new NSCLC diagnoses. Yet, no therapies are approved specifically for this subset of patients, despite the distinct molecular drivers and limited treatment options after failure of kinase targeted therapies. Lantern estimates this group represents a global market opportunity exceeding $4 billion annually.

RADR(R) was built to address exactly this kind of niche: genetically defined cancers with unmet needs. By leveraging machine learning, computationally-driven mechanistic biology, and biomarker discovery, Lantern is not only identifying drug candidates but also helping design trials that focus on populations most likely to benefit. According to the company, RADR(R) has processed over 200 billion oncology-specific data points to date, enabling the advancement of multiple clinical programs.

In addition to LP-300, Lantern’s pipeline includes two other small molecule candidates (LP-184, in a Phase 1a trial for advanced solid tumors and glioblastoma multiforme, and LP-284, in a Phase 1 trial for relapsed or refractory non-Hodgkin’s lymphoma and other solid tumors), an antibody-drug conjugate program, and programs in CNS and brain cancers. All of the programs are being developed using RADR(R) to streamline discovery and development timelines. The company is also engaged in research partnerships with academic institutions and global trial networks.

Clinical updates from the HARMONIC(TM) trial are expected through the second half of 2025 as enrollment progresses.

For more information, visit the company’s website at www.LanternPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to LTRN are available in the company’s newsroom at https://ibn.fm/LTRN

• ONAR’s technology-first approach combines its proprietary AI platform with strategic agency acquisitions to deliver measurable marketing results for middle-market companies
• Recent board appointment of advertising innovator Jon Bond reinforces ONAR’s positioning at the intersection of creativity and technology in the evolving martech landscape
• The company’s integrated model leverages AI automation across performance media, SEO, and healthcare marketing through its network of agencies

The marketing technology sector finds itself at a crossroads that extends far beyond the typical innovation cycle. As adtech companies scramble to incorporate artificial intelligence into their offerings, launching everything from automated creative platforms to machine learning optimization tools, a critical distinction is emerging between organizations that deploy AI strategically versus those that implement it reactively. The difference lies not in the sophistication of the technology itself, but in how deeply AI capabilities are woven into core business operations.

The reality is that most current AI deployments follow a fragmented approach. Companies introduce AI capabilities piecemeal: optimization suggestions in one area, automated reporting in another, predictive analytics as a separate module. While each component may deliver incremental value, this scattered implementation prevents AI from reaching its full potential as a learning system that improves through interconnected data flows.

This fragmentation has opened the door for companies that recognize a key market insight: the most valuable implementations are those that create unified intelligence across the entire marketing ecosystem, where insights from one area continuously inform and enhance performance in others.

That’s a sweet spot for ONAR Holding Corp. (OTCQB: ONAR), a technology-first network of marketing agencies that has positioned itself nicely within this AI-driven revolution in adtech.

Integrated AI Architecture Delivers Real Performance

ONAR’s competitive advantage lies in understanding what many adtech companies miss: AI’s transformational power comes from system-wide integration, not isolated features. The company’s model blends strategic services, AI-driven insights and scalable execution to give companies the tools and support they need to scale quickly and smartly – something that larger agencies can’t always do with smaller companies.

Originally developed by ONAR’s flagship agency Storia, Cortex creates closed-loop feedback cycles essential for meaningful AI impact. The platform ingests real-time first-party data across campaign touchpoints, analyzes audience response and creative performance in context, then feeds insights back into the system to improve subsequent decisions and activations.

Currently, Storia clients access Cortex at no additional cost, demonstrating ONAR’s commitment to treating AI as core infrastructure rather than an expensive add-on. This philosophy aligns with industry insights suggesting that companies treating AI as essential infrastructure will be best positioned to lead in the evolving adtech landscape.

Strategic Leadership Reinforces AI Vision

ONAR’s recent appointment of Jon Bond to its Board of Directors signals serious intent to accelerate its AI-driven growth strategy. Bond brings decades of experience from the intersection of creativity and technology, having co-founded Kirshenbaum & Bond, pioneered programmatic media through ventures like Varick, and served as CEO of Big Fuel before its acquisition by Publicis.

“I have spent my career at the intersection of creativity and technology, building businesses that challenge current industry norms,” Bond stated in announcing his appointment. His experience with AI-powered media company Inuvo and his nomination for the 2025 Advertising Hall of Fame underscore his understanding of how artificial intelligence can transform marketing effectiveness.

Bond’s appointment addresses the critical need for leadership that understands both creative strategy and technological implementation, a combination essential for successful AI integration in agency environments.

End-to-End Integration Creates Competitive Advantage

ONAR’s strategy extends beyond technological development to deliver AI-driven adtech that matters to all businesses. The company’s portfolio, including Storia (performance marketing and SEO) and Of Kos (full-service marketing for the healthcare industry), creates an interconnected system where each agency component communicates with the others, enabling Cortex to deliver system-wide intelligence rather than isolated optimizations.

This integrated approach enables dynamic performance optimization that defines next-generation adtech. Cortex can analyze audience response patterns across Storia’s performance campaigns, using all the information available to create cross-pollination of insights impossible in siloed systems.

ONAR Labs, the company’s dedicated technology development division, ensures continuous innovation through its team of data scientists, engineers, and industry experts working alongside professionals. This structure keeps technology development grounded in real-world client needs rather than theoretical applications.

Market Positioning and Growth Potential

The timing of ONAR’s AI-first approach appears strategically sound. It’s arguable that marketers who can effectively combine AI’s capabilities with human expertise will have a clear advantage in 2025, crafting campaigns that are both scalable and deeply resonant. Organizations that successfully integrate AI across their operations are positioning themselves to capture significant competitive advantages in efficiency, speed, and revenue generation.

ONAR’s focus on middle-market and growth-stage companies addresses a market segment that often lacks access to enterprise-level marketing technology. As AI adoption accelerates across the marketing industry, this creates substantial growth opportunities for companies that can deliver sophisticated AI capabilities at accessible price points.

For more information, visit the company’s website at www.ONAR.com.

NOTE TO INVESTORS: The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR

• LaFleur Minerals plans to restart its fully-permitted and recently refurbished Beacon Gold Mill in Val-d’Or, Quebec, by early 2026, offering many surrounding gold projects a much-needed nearby milling option.
• In addition, a minimum 5,000-metre diamond drilling program is launching at the company’s wholly-owned 166 km² Swanson Gold Project this month, and a Preliminary Economic Assessment (“PEA”) is underway to evaluate open-pit mining and milling scenarios at current gold prices, as they rise above $3,300/oz, expected to hit $4,000/oz by the second quarter of 2026, JP Morgan analysts say.
• In support of the company’s Swanson Project plans for a 100,000-tonne bulk sample to be processed at the Beacon Mill, LaFleur expects a conservative restart cost of C$5-6 million, which includes further upgrades, benefitting from no outstanding royalties or encumbrances, providing investors both near-term production potential and exposure to the upside of surging gold, with a site visit planned for July 2025 for prospective investors and analysts.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF), a Canadian near-term gold producer, is making steady progress toward restarting its 100%-owned Beacon Gold Mill in Val-d’Or, Quebec, and launching a large-scale bulk sampling program at its Swanson Gold Project (https://ibn.fm/ywO6A). The company aims to reinitiate gold production by early 2026, situated in Canada’s most prolific gold-producing region, aligning with record-high gold prices now exceeding US$3,300 per ounce.

LaFleur acquired the Beacon Gold Mill, strategically located in Quebec’s Abitibi Gold Belt, in late 2024. The facility had already been given over C$20 million in repairs and upgrades under its previous owner, Monarch Mining, before being acquired under opportunistic terms by what is now known as LaFleur. Fully permitted, the mill represents a rare opportunity to accelerate gold production timelines, and offers a nearby milling option for surrounding gold projects, of which the region is well-endowed, with more than 100 historical and operating mines ideal as potential sources of ore.

The mill is permitted to process 750 tonnes per day and benefits from access to road, power, and a skilled local workforce. With additional upgrades, the mill will be ready to also handle bulk samples from LaFleur’s own Swanson Gold Project. A detailed mill restart plan has been developed, outlining C$3.8 million in equipment upgrades and C$1.8 million in tailings facility repairs needed. Notably, the mill is free of royalties or financial encumbrances, following the elimination of prior claims during Monarch’s restructuring, and new, prospective investors have already expressed interest.

CEO Paul Ténière said in a statement that LaFleur is executing a “methodical” restart strategy. “We are grateful to have acquired the fully permitted and refurbished Beacon Gold Mill, which received over C$20 million in upgrades by its previous operator and is located in the midst of numerous gold deposits in the historic Val-d’Or and Rouyn-Noranda mining districts, including our own Swanson Gold Deposit,” he said. “Based on our recent detailed assessments, the Beacon Gold Mill requires minimal repairs and improvements, and we are methodically executing a strategy to eventually restart production at the mill.”

According to LaFleur, the mill restart will be closely tied to material sourced from the nearby Swanson Gold Project, which spans 166 km² and contains four key targets: Swanson, Bartec, Marimac, and Jolin. The company is currently preparing to extract a 100,000-tonne bulk sample from the Swanson site for metallurgical testing at the Beacon Mill. A bulk sample and environmental remediation plan is under review by Quebec regulators. These well-positioned assets held by LaFleur form part of the company’s vertically-integrated gold producing model, reducing operational risks while enhancing the overall potential economics and value proposition of both properties.

The Swanson deposit currently hosts an Indicated resource of 123,400 ounces of gold at an average grade of 1.8 g/t and an Inferred resource of 64,500 ounces at 2.3 g/t, based on the most recent NI 43-101 report filed in September 2024. A Preliminary Economic Assessment (“PEA”) is underway to evaluate the economic potential of an open-pit mining operation combined with milling at Beacon.

“We are also excited to commence planning for a large bulk sample at Swanson and a PEA to evaluate a mining and processing scenario at current record gold prices,” Ténière added. “With gold prices at record highs this is a pivotal year for LaFleur Minerals as we focus on restarting gold production at the Beacon Gold Mill and diamond drilling at the Swanson Gold Project to increase mineral resources.”

The company is also beginning a 5,000-metre diamond drilling campaign this month, targeting new and historical gold occurrences across its land package. Over 50 drill targets have been identified, and previous sampling at the Jolin prospect returned values as high as 11.7 g/t gold.

A site visit to both the Beacon Mill and Swanson project is planned for July 2025. LaFleur invites investors, analysts, and prospective partners to attend and assess the facilities firsthand. The company is also in discussions with multiple parties to fund the restart phase.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

• Silvercorp’s Q4 revenue rose 76% year-over-year to $75.1 million.
• Operating cash flow for the quarter reached $30.7 million, nearly tripling the $10.2 million reported in Q4 Fiscal 2024.
• $13 million was invested into growth projects.
• Even after investments made, Silvercorp added $14.5 million to cash, ending Fiscal 2025 with cash and short-term investments of $369.1 million.

Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc, with a long history of profitability, delivered its strongest fourth-quarter performance to date, closing out Fiscal 2025, ended March, with significant growth in both revenue and operating cash flow. The results reflect a combination of increased production volumes and stronger realized prices across the company’s key metals (https://ibn.fm/RuJVg).

Revenue for Q4 Fiscal 2025 reached $75.1 million, a 76% increase compared to $42.7 million in the same quarter last year. The growth was fueled by higher production—up 62% for gold and 42% for silver—and rising commodity prices, particularly a 33% increase in gold and 34% in silver.

Cash flow from operating activities was $30.7 million in the quarter, nearly tripling the $10.2 million reported in Q4 of the prior year. On a full-year basis, operating cash flow totaled $138.6 million.

Income from mine operations in the quarter climbed to $26.1 million, up from $13.0 million in Q4 Fiscal 2024. Silvercorp also increased capital investments in its core operations, spending $9.9 million in China and $3.1 million on its El Domo project in Ecuador during the quarter.

Even after these investments, the company added cash to its balance sheet and reported cash and short-term investments of $369.1 million, up from $354.6 million at the end of December 2024. It also held a $70.9 million portfolio of equity investments and has access to a $175 million stream financing credit to support El Domo mine construction.

To quickly summarize the full year results, just like the quarter, Fiscal 2025 was a record-breaking year across the board. As a growing and profitable silver producer that provides leverage to higher metals prices, these results reinforce why Silvercorp remains a compelling investment.

A clarification for investors is that, while earnings per share were slightly lower than some estimates, two accounting items contributed to this result. The first was a $20.6 million non-cash charge related to the fair value of derivative liabilities linked to the conversion rights of convertible notes and warrants. The second was a reclassification of certain mining preparation costs, which were expensed during the quarter. Neither of these items impacted cash flow.

The company completed its all-share acquisition of Adventus Mining Corporation during the fiscal year, adding the El Domo and Condor projects in Ecuador to its development pipeline.

Development efforts are progressing across multiple fronts. At the El Domo Copper-Gold Project, the company released an updated construction budget to $240.5 million, slightly below previous feasibility study estimate of $248 million. Production is expected to begin by the end of 2026.

Separately, an updated mineral resource estimate for the Condor Gold Project was released recently. The revised estimate will support a Preliminary Economic Assessment for a high-grade underground operation, expected to be completed later this year. In parallel, a 3,500-metre surface drilling campaign is now underway to refine exploration targets.

Silvercorp also declared a semi-annual dividend of US$0.0125 per share, payable by June 26, 2025, to shareholders of record, as of a June 6 announcement (https://ibn.fm/dtCfs).

With a growing portfolio of projects in Ecuador and China, and a disciplined approach to spending and development, Silvercorp remains focused on generating long-term shareholder value. Its 18-year track record of profitability, combined with a strong balance sheet and robust cash flows, offers a compelling opportunity for investors.

For more information, visit the company’s website at www.silvercorpmetals.com/welcome.

Third-Party Content Disclaimer

The IBN website may contain third-party content articles and other content submitted by third parties, including articles submitted through the IBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IBN providing you with this internet portal that makes accessible to you the ability to view third party content through the IBN site, IBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IBN expressly disclaims liability relating to such third-party content. IBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://IBN.fm/Disclaimer.

• Brera has entered an advisory agreement with Toronto Blizzard to develop talent pathways in global soccer.
• Youth sports are projected to grow to $69.4 billion by 2030, with sports tourism valued at $91.8 billion in 2021.
• The partnership builds on Blizzard’s existing prominence in girls soccer and aims to expand access to international player development.
• Brera plans to connect Blizzard players to its network of clubs in Italy, North Macedonia, Mongolia, and Mozambique.
• Talent identification camps and European academy visits are planned for summer 2026 or sooner.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, is expanding into youth soccer development through a strategic partnership with Toronto Blizzard Corp. The initiative is aimed at tapping into the rapidly growing global youth sports industry, which is expected to reach $69.4 billion by 2030, according to Profluence.com (https://ibn.fm/2LmqS).

Under an advisory agreement, Brera will collaborate with the Blizzard, Canada’s leading soccer scholarship platform founded and led by Soccer Hall of Famer Giuseppe “Joe” Parolini, to connect its youth development pipeline to Brera’s international football network. The initiative will focus on expanding opportunities for young players, especially by offering exposure to professional training environments in Europe and beyond.

The Blizzard Development Academy already has a strong track record of preparing youth for college scholarships and professional development. The new agreement aims to strengthen this pipeline by linking Blizzard players, ages 3 to 18, with Brera clubs in Italy, North Macedonia, Mongolia, and Mozambique. These include SS Juve Stabia (Italy’s Serie B), Brera Strumica FC and Brera Tiverija FC in North Macedonia, and others.

Blizzard programs such as “Little Blizzard Kickers” (ages 3 to 7) and advanced academies (ages 8 to 18) will incorporate Brera coaching methods, with shared curriculum and direct interaction with coaches and players from the European clubs.

“Brera Holdings is the perfect partner to help bring new coaching philosophies to talented youth in Ontario. When I took over the ownership of the Blizzard in 1999, ensuring equal opportunities for women and girls to play and receive the same quality of training and development was very important to me,” said Parolini. “Through this partnership I believe we can identify talent, develop and create pathways to other opportunities such as Juve Stabia in Naples where I was born, Brera Strumica and Tiverjia in North Macedonia, the World Squad, and more.” 

As part of the agreement, talent identification camps in the Greater Toronto Area are scheduled to begin by summer 2026 or earlier, with selected players gaining opportunities to train at Brera academies in Europe. Blizzard will coordinate and promote the camps, while Brera clubs will deliver coaching and training.

The initiative also targets the rapidly growing sports tourism sector, which had a $91.8 billion economic impact in 2021, as noted by Profluence.com. The collaboration includes plans for friendly matches between Brera-owned clubs and Canadian teams, though these are contingent on financial sustainability.

Beyond immediate player development, the value proposition of the program also lies in college recruitment. According to Profluence, 88% of women’s college soccer players and 77% of men’s come from club-level systems like the Blizzard’s. With private college tuition reaching $33,000 per year (up from $11,000 in 1981), athletic scholarships represent an increasingly important financial opportunity for families.

Brera’s multi-club ownership model is modeled on a broader industry trend, where clubs and holding companies seek to build scalable platforms for player development and commercial opportunities. This deal adds youth infrastructure in North America to Brera’s global reach and diversifies its exposure to the lucrative youth sports economy. With its global football network and commitment to accessible talent development, Brera Holdings is positioning itself not just as an owner of clubs, but as an enabler of cross-border player growth, targeting one of the most dynamic sectors in sports today.

Brera’s Executive Chairman, Daniel J. McClory, emphasized the significance of connecting Canadian youth with international football ecosystems. 

“We’ve seen the incredible soccer talent coming from Canada, as well as at the NCAA programs of U.S. universities where Blizzard alumni have distinguished themselves. Our partnership with Toronto Blizzard will allow us to share our clubs’ coaching philosophies as well as identify and help develop young talent in Toronto,” he said. “We look forward to introducing this partnership to the Province of Ontario with the Blizzard, and bringing players to train at the academies of our clubs in Italy and North Macedonia, as these countries enjoy longstanding and particularly strong cross-cultural ties with the Toronto metro area.”

For more information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, offering substantial resource potential and long-term production growth.
• The company’s projects demonstrate strong economic fundamentals, with high internal rates of return and low all-in sustaining costs per ounce of silver.
• Bolivia’s underexplored mineral potential presents a strategic advantage for New Pacific Metals, allowing it to capitalize on a historically rich mining region.
• The company is backed by two strategic shareholders: Silvercorp Metals (28%) and Pan American Silver (12%).
• The company is supported by an experienced leadership team with a track record of success in mineral exploration, development, and corporate finance.
• As global silver demand increases for industrial and renewable energy applications, New Pacific Metals is well-positioned to benefit from market growth and rising silver prices.

New Pacific Metals (NYSE American: NEWP) (TSX: NUAG) is a Canadian exploration and development company focused on advancing world-class silver projects in Bolivia. The company’s primary asset, the Silver Sand project, has the potential to become one of the largest silver mines globally, supported by robust economic assessments. Additionally, the company is progressing its Carangas project, a silver-lead-zinc deposit with scale.

New Pacific Metals aims to create long-term value for its shareholders by advancing and de-risking its quality silver assets while contributing to the economic growth of Bolivia.

New Pacific Metals is headquartered in Vancouver, British Columbia, Canada.

Projects

Silver Sand Project

The flagship Silver Sand project is a high-grade silver deposit with an expected mine life of 13 years. A preliminary feasibility study (“PFS”) completed in June 2024 estimates an annual production of 12 million ounces of silver, including 15 million ounces in the first three years of operation, with total projected production reaching 157 million ounces. The project has a post-tax net present value (“NPV5%”) of $740 million at a silver price of $24 per ounce and an internal rate of return (“IRR”) of 37%. With a low all-in sustaining cost (“AISC”) of $10.69 per ounce and a 1.9-year payback period, Silver Sand presents a rare and compelling silver opportunity.

Carangas Project

The Carangas project is an emerging silver-lead-zinc deposit with a 16-year mine life. A preliminary economic assessment (“PEA”) completed in September 2024 indicates an annual production of 6.6 million ounces of silver, with total production projected at 106 million ounces. The project boasts an after-tax NPV5% of $501 million, an IRR of 26%, and a payback period of 3.2 years at $24 per ounce silver. Its low AISC of $7.60 per ounce positions Carangas as a high-margin operation with significant upside potential. The PEA preserves Carangas’ significant gold (1+ million ounces) potential at depth.

Market Opportunity

The global silver market continues to see increasing demand driven by industrial applications, investment interest, and the growing use of silver in renewable energy technologies. Bolivia, ranked as the fourth-largest silver-producing country, presents significant untapped potential due to limited modern exploration.

The Silver Sand and Carangas projects represent two of the largest undeveloped open-pit silver projects in the world, with the potential to deliver substantial production volumes. As silver prices remain favorable and demand continues to rise, New Pacific Metals is positioned to play a crucial role in supplying the global silver market.

Leadership Team

Dr. Rui Feng, Founder, is a geologist and entrepreneur with over 25 years of experience in mineral exploration and project development. In 2003, Dr. Feng founded Silvercorp, acquiring early-stage properties in China. Through discovery and development, Silvercorp has become one of the most profitable Canadian mining companies, with multiple mines in China. Building on that success, Dr. Feng established New Pacific Metals, where he has been instrumental in the discovery and advancement of its key projects. With a track record of building successful mining ventures, he continues to provide strategic insight to the company’s growth initiatives.

Jalen Yuan, Interim CEO, is a corporate leader and professional accountant with over sixteen years of diverse international experience in the mining industry.  Mr. Yuan has been deeply involved in all of the company’s strategic decisions as Chief Financial Officer since 2015, including those related to the acquisition, exploration, technical studies, and permitting of the Silver Sand and Carangas projects in Bolivia, prior to his appointment as Interim Chief Executive Officer in April 2025. Mr. Yuan also played instrumental roles in the company’s financing activities, raising a total of US$130 million since 2017.

Dickson Hall, Chairman of the Board of Directors, has over 40 years of experience in finance and corporate development, with a strong emphasis on the mining sector. He is a Partner at Valuestone Advisors Limited, sole advisor of Valuestone Global Resource Fund 1, and a director of Bunker Hill Mining Corp. and MEC Advisors Limited. Fluent in Mandarin and well-experienced in Chinese business culture, Mr. Hall has worked with an extensive group of multinationals, trade associations, and government organizations with China operations. He is a graduate of the University of British Columbia.

For more information, visit the company’s website at www.NewPacificMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP

AI World Society (“AIWS”) Circle, a place where narratives on the future are crafted and shaped by the transformative power of artificial intelligence (“AI”), is proud to announce the After Hours AI World Society Circle, New York City Chapter. This will be a night of networking and discussions on the impact of AI on society, as well as an opportunity to expand one’s knowledge on the topic.

This in-person event will be held at the prestigious Harvard Club of New York City, bringing together AI enthusiasts, industry professionals, and thought leaders in a relaxed and engaging setting. It will build upon the success of previous AIWS events, which have been lauded for providing superior networking opportunities while offering a wealth of knowledge to attendees.

Since its inception, AIWS has fostered a community that thrives on collaboration, offering a platform for open dialogue, engaging live conferences, and unique experiences that propel the AI conversation forward. By delivering the insights and resources needed to navigate the global AI landscape, attendees leave the event empowered and well-equipped with a deeper understanding and valuable networks that foster innovation.

According to McKinsey, AI adoption has increased tremendously in just the past year, which is no surprise to followers of technology. In a recent study, 78% of respondents reported that their organizations utilized AI in at least one business function, up from 72% in early 2024 and 55% the previous year. AI’s usage, specifically for tasks such as IT, has grown from 27% to 36% in just the past six months, pointing to the significance of the technology and its usefulness for businesses. As it continues to rapidly evolve, people need to stay ahead of the curve, and the After Hours AI World Society Circle presents attendees with an opportunity to do so. Those who are unable to embrace the technology are clearly at risk.

The New York City Chapter will precede a similar event to be held in San Francisco later in September. It will also set the stage for the 3^rd Annual AI World Week that will take place in Washington, DC, on October 8. Just like all the other AIWS events, attendees can expect engaging discussions, critical insights and updates from industry leaders, along with important AI start-up pitches.

To learn more, please visit https://ibn.fm/54kHs

• The three parties signed an MOU focusing on research collaboration, education, and commercial use case development.
• MOU facilitates the organizations’ efforts towards the acquisition of a D-Wave Advantage2(TM) system at the Yonsei University International Campus.
• The collaboration aims to advance mutual research and talent development for quantum computing, provide access to D-Wave’s quantum computing technology, and explore the development of use cases in biotechnology, materials science and other areas.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has entered into a strategic partnership with Yonsei University and Incheon Metropolitan City designed to accelerate quantum computing adoption and commercialization in South Korea. The company announced the signing of a memorandum of understanding (“MOU”) on June 17, outlining plans for quantum computing research, education, and collaboration (https://ibn.fm/0NaSv).

A central aim of the initiative is to facilitate the acquisition of a D-Wave Advantage2 system at Yonsei University’s International Campus in Songdo, Incheon. Installing such a system in South Korea would mark a step forward in the region’s broader quantum infrastructure ambitions. Under the terms of the MOU, the parties plan to also explore quantum computing’s potential use cases in sectors such as biotechnology and materials science. 

The partnership follows the recent announcement of general availability of the Advantage2 quantum computing system, which marked the release of what the company calls its most performant system yet, delivering energy-efficient, scalable quantum processing capable of tackling some problems that are beyond the capabilities of classical computing. The system features more than 4,400 qubits and is available through D-Wave’s Leap(TM) real-time quantum cloud service and for on-premises deployment by enterprises and research institutions.

“This collaboration with D-Wave and Incheon Metropolitan City supports our mission to facilitate a collaborative ecosystem for quantum computing literacy, research and commercial application development,” said Dong-Sup Yoon, president of Yonsei University. Yoon added that having a D-Wave annealing quantum computer onsite would offer “significant opportunities to advance industry and research in South Korea.”

For Incheon Metropolitan City, the MOU aligns with broader ambitions to become a global technology hub. “We have a unique opportunity to establish Incheon as a global quantum hub,” said Mayor Yoo Jeong-bok, citing the region’s established strengths in the bio industry and its potential to attract global quantum talent. “Building on Incheon’s strengths in the bio industry and other key sectors, we anticipate the emergence of a true quantum cluster where quantum technology converges with various industries to create innovative breakthroughs and attract top talent from around the world,” the mayor added.

According to Dr. Alan Baratz, CEO of D-Wave, the initiative represents both a regional and international milestone. “This strategic relationship marks an important step in furthering D-Wave’s mission to accelerate global quantum computing adoption,” said Dr. Baratz. “Yonsei University and Incheon Metropolitan City recognize the remarkable, immediate opportunity for scientific breakthroughs and business transformation possible with D-Wave’s quantum computing technology. We look forward to the possibility of installing a system at Yonsei University to further establish its role as a global quantum hub.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.